Striatal Pre- and Postsynaptic Profile of Adenosine A2A Receptor Antagonists
2011

Study of Adenosine A2A Receptor Antagonists in Striatal Neurons

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Orru Marco, Bakešová Jana, Brugarolas Marc, Quiroz César, Beaumont Vahri, Goldberg Steven R., Lluís Carme, Cortés Antoni, Franco Rafael, Casadó Vicent, Canela Enric I., Ferré Sergi

Primary Institution: National Institute on Drug Abuse, IRP, NIH, DHHS, Baltimore, Maryland, United States of America

Hypothesis

Selective A2A receptor antagonists may be subdivided according to a preferential pre- versus postsynaptic mechanism of action.

Conclusion

The study found that SCH-442416 and KW-6002 have distinct pre- and postsynaptic profiles, which could inform the development of more effective treatments for Parkinson's disease and dyskinetic disorders.

Supporting Evidence

  • SCH-442416 showed a significant preferential presynaptic profile.
  • KW-6002 demonstrated a strong locomotor activation.
  • Four other compounds showed mixed pre- and postsynaptic profiles.
  • Heteromerization plays a key role in the presynaptic profile of SCH-442416.
  • KW-6002 had the best relative affinity for A2AR co-expressed with D2R.

Takeaway

This study looked at how different drugs affect brain cells involved in movement, finding that some drugs work better in certain parts of the brain.

Methodology

The study used in vivo models to evaluate the effects of A2A receptor antagonists on locomotor activity and striatal glutamate release.

Limitations

The study was conducted on a limited number of animal models and may not fully represent human conditions.

Participant Demographics

Male Sprague-Dawley rats weighing between 300–350 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016088

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication